Which has grown faster, MRNA or STE?

Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus STE at 5.93%.

Does MRNA or STE pay a bigger dividend?

STE pays a dividend (1.06% yield), while MRNA has no payments in the available dividend history.

Is MRNA or STE more profitable?

STE runs the higher net margin — MRNA at -141.43% versus STE at 13.31%.

How have MRNA and STE total returns compared?

Over the past 5 years, MRNA delivered -32.21% and STE delivered 13.80% annualized total return. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs STERIS plc (STE)

A side-by-side comparison of Moderna, Inc. and STERIS plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

MRNA

Moderna, Inc.

$23.67B

$59.65HealthcareDelayed quote: Aug 10, 2026, 12:20 PM EDT

STE

STERIS plc

$23.05B

$236.48HealthcareDelayed quote: Aug 10, 2026, 12:20 PM EDT

Total return — MRNA vs STE

growth of $100 · dividends reinvested · last 8y

MRNA +218.1% (+15.6%/yr)STE +123.9% (+10.6%/yr)MRNA compounded faster over this window

MRNA STE

MRNA vs STE: by the numbers

•MRNA is the larger company ($23.67B vs $23.05B market cap).
•STE is profitable (13.31% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 5.93% CAGR).
•STE pays a dividend (1.06% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MRNA	STE
P/E ratio	N/A	29.03
Forward P/E	N/A	23.29
P/S ratio	10.52	3.86
P/B ratio	3.47	3.19
EV / EBITDA	N/A	13.45
FCF yield	N/A	4.24%

Profitability

Metric	MRNA	STE
Gross margin	55.35%	43.97%
Operating margin	-158.13%	18.83%
Net margin	-141.43%	13.31%
ROE	-46.61%	8.38%
ROIC	-29.70%	8.47%

Dividends

Metric	MRNA	STE
Dividend yield	N/A	1.06%
Payout ratio	N/A	31.78%

Growth (annualized)

Metric	MRNA	STE
Revenue CAGR (5Y)	19.33%	5.93%
EPS CAGR (5Y)	N/A	11.22%
FCF CAGR (5Y)	N/A	16.89%
Total return CAGR (5Y)	-32.21%	2.86%

Frequently asked

Which has grown faster, MRNA or STE?: Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus STE at 5.93%.
Does MRNA or STE pay a bigger dividend?: STE pays a dividend (1.06% yield), while MRNA has no payments in the available dividend history.
Is MRNA or STE more profitable?: STE runs the higher net margin — MRNA at -141.43% versus STE at 13.31%.
How have MRNA and STE total returns compared?: Over the past 5 years, MRNA delivered -32.21% and STE delivered 13.80% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full STE analysis Interactive comparison tool

Dig into the metrics

STERIS P/E ratio STERIS dividend yield Moderna ROE STERIS ROE Moderna operating margin STERIS operating margin Moderna revenue growth STERIS revenue growth Moderna free cash flow STERIS free cash flow

Moderna & STERIS appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.